Author:
Ling Fei-Xiang,Qu Dong-Ming,Lu Ye-Quan,Li Rou,Zhao Lei
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Rashbi KS, Ali T. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India. Access Microbiol. 2022;4(6):acmi360.
2. Garcia-Carnero LC, Mora-Montes HM. Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis[J]. J Fungi (Basel). 2022;8(5):445–5.
3. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009;15(9):1395–401.
4. Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044–50.
5. Schmiedel Y, Zimmerli S. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly. 2016;146:w14281.